Inhalable Treatment Enhances Regeneration in Lung Fibrosis Model
A new study highlights the potential of a novel, inhalable regenerative therapy for the treatment of idiopathic pulmonary fibrosis.
University of California San Francisco
Rapid COVID-19 Test Shows Promise in Community Test Setting
Preliminary data from a study by UCSF and Chan Zuckerberg Biohub scientists suggests that new rapid COVID-19 tests – if used correctly and alongside existing gold-standard PCR tests – could be a valuable tool to accelerate the COVID-19 public health response.
Struggling Sea Lions May Benefit from UCSF Neuroscience Research
A cellular therapy for epilepsy developed at UCSF has been employed for the first time in a sea lion with intractable seizures caused by ingesting toxins from algal blooms.
DNA Test Identifies Genetic Causes of Severe Fetal and Newborn Illness
A new study by University of California researchers shows the promise of high-throughput DNA-sequencing technologies to improve prenatal diagnosis and pregnancy outcomes for women who have experienced an abnormal prenatal ultrasound.
UCSF, Fortanix, Intel, and Microsoft Azure Utilize Privacy-Preserving Analytics to Accelerate AI in Health Care
UC San Francisco’s Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure have formed a collaboration to establish a confidential computing platform with privacy-preserving analytics to accelerate the development and validation of clinical algorithms.
New Gift Fuels Precision Medicine Approaches to Diabetes
A generous gift of $1 million from an anonymous donor recently created the Breakthrough Initiative in Type 1 Diabetes Precision Medicine and Discovery.